Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Collections
  • About
    • General information
    • Staff
    • Editorial board
    • Open access
    • Contact
  • CMAJ JOURNALS
    • CMAJ
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ Open
  • CMAJ JOURNALS
    • CMAJ
    • CJS
    • JAMC
    • JPN
CMAJ Open

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Collections
  • About
    • General information
    • Staff
    • Editorial board
    • Open access
    • Contact
  • RSS feeds
Research

Use of real-world evidence in cancer drug funding decisions in Canada: a qualitative study of stakeholders’ perspectives

Marc Clausen, Chloe Mighton, Ruhi Kiflen, Agnes Sebastian, Wei Fang Dai, Rebecca E. Mercer, Jaclyn M. Beca, Wanrudee Isaranuwatchai, Kelvin K.W. Chan and Yvonne Bombard
November 24, 2020 8 (4) E772-E778; DOI: https://doi.org/10.9778/cmajo.20200118
Marc Clausen
Li Ka Shing Knowledge Institute (Clausen, Mighton, Sebastian, Isaranuwatchai, Bombard), St. Michael’s Hospital, Unity Health; Institute of Health Policy, Management and Evaluation (Mighton, Sebastian, Beca, Isaranuwatchai, Bombard), University of Toronto; Canadian Cancer Society (Kiflen); Cancer Care Ontario (Dai, Mercer, Beca, Chan), Ontario Health; Canadian Centre for Applied Research in Cancer Control (Dai, Mercer, Beca, Isaranuwatchai, Chan); Sunnybrook Health Sciences Centre (Chan), Toronto, Ont.
MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chloe Mighton
Li Ka Shing Knowledge Institute (Clausen, Mighton, Sebastian, Isaranuwatchai, Bombard), St. Michael’s Hospital, Unity Health; Institute of Health Policy, Management and Evaluation (Mighton, Sebastian, Beca, Isaranuwatchai, Bombard), University of Toronto; Canadian Cancer Society (Kiflen); Cancer Care Ontario (Dai, Mercer, Beca, Chan), Ontario Health; Canadian Centre for Applied Research in Cancer Control (Dai, Mercer, Beca, Isaranuwatchai, Chan); Sunnybrook Health Sciences Centre (Chan), Toronto, Ont.
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ruhi Kiflen
Li Ka Shing Knowledge Institute (Clausen, Mighton, Sebastian, Isaranuwatchai, Bombard), St. Michael’s Hospital, Unity Health; Institute of Health Policy, Management and Evaluation (Mighton, Sebastian, Beca, Isaranuwatchai, Bombard), University of Toronto; Canadian Cancer Society (Kiflen); Cancer Care Ontario (Dai, Mercer, Beca, Chan), Ontario Health; Canadian Centre for Applied Research in Cancer Control (Dai, Mercer, Beca, Isaranuwatchai, Chan); Sunnybrook Health Sciences Centre (Chan), Toronto, Ont.
MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Agnes Sebastian
Li Ka Shing Knowledge Institute (Clausen, Mighton, Sebastian, Isaranuwatchai, Bombard), St. Michael’s Hospital, Unity Health; Institute of Health Policy, Management and Evaluation (Mighton, Sebastian, Beca, Isaranuwatchai, Bombard), University of Toronto; Canadian Cancer Society (Kiflen); Cancer Care Ontario (Dai, Mercer, Beca, Chan), Ontario Health; Canadian Centre for Applied Research in Cancer Control (Dai, Mercer, Beca, Isaranuwatchai, Chan); Sunnybrook Health Sciences Centre (Chan), Toronto, Ont.
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wei Fang Dai
Li Ka Shing Knowledge Institute (Clausen, Mighton, Sebastian, Isaranuwatchai, Bombard), St. Michael’s Hospital, Unity Health; Institute of Health Policy, Management and Evaluation (Mighton, Sebastian, Beca, Isaranuwatchai, Bombard), University of Toronto; Canadian Cancer Society (Kiflen); Cancer Care Ontario (Dai, Mercer, Beca, Chan), Ontario Health; Canadian Centre for Applied Research in Cancer Control (Dai, Mercer, Beca, Isaranuwatchai, Chan); Sunnybrook Health Sciences Centre (Chan), Toronto, Ont.
MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rebecca E. Mercer
Li Ka Shing Knowledge Institute (Clausen, Mighton, Sebastian, Isaranuwatchai, Bombard), St. Michael’s Hospital, Unity Health; Institute of Health Policy, Management and Evaluation (Mighton, Sebastian, Beca, Isaranuwatchai, Bombard), University of Toronto; Canadian Cancer Society (Kiflen); Cancer Care Ontario (Dai, Mercer, Beca, Chan), Ontario Health; Canadian Centre for Applied Research in Cancer Control (Dai, Mercer, Beca, Isaranuwatchai, Chan); Sunnybrook Health Sciences Centre (Chan), Toronto, Ont.
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jaclyn M. Beca
Li Ka Shing Knowledge Institute (Clausen, Mighton, Sebastian, Isaranuwatchai, Bombard), St. Michael’s Hospital, Unity Health; Institute of Health Policy, Management and Evaluation (Mighton, Sebastian, Beca, Isaranuwatchai, Bombard), University of Toronto; Canadian Cancer Society (Kiflen); Cancer Care Ontario (Dai, Mercer, Beca, Chan), Ontario Health; Canadian Centre for Applied Research in Cancer Control (Dai, Mercer, Beca, Isaranuwatchai, Chan); Sunnybrook Health Sciences Centre (Chan), Toronto, Ont.
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wanrudee Isaranuwatchai
Li Ka Shing Knowledge Institute (Clausen, Mighton, Sebastian, Isaranuwatchai, Bombard), St. Michael’s Hospital, Unity Health; Institute of Health Policy, Management and Evaluation (Mighton, Sebastian, Beca, Isaranuwatchai, Bombard), University of Toronto; Canadian Cancer Society (Kiflen); Cancer Care Ontario (Dai, Mercer, Beca, Chan), Ontario Health; Canadian Centre for Applied Research in Cancer Control (Dai, Mercer, Beca, Isaranuwatchai, Chan); Sunnybrook Health Sciences Centre (Chan), Toronto, Ont.
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kelvin K.W. Chan
Li Ka Shing Knowledge Institute (Clausen, Mighton, Sebastian, Isaranuwatchai, Bombard), St. Michael’s Hospital, Unity Health; Institute of Health Policy, Management and Evaluation (Mighton, Sebastian, Beca, Isaranuwatchai, Bombard), University of Toronto; Canadian Cancer Society (Kiflen); Cancer Care Ontario (Dai, Mercer, Beca, Chan), Ontario Health; Canadian Centre for Applied Research in Cancer Control (Dai, Mercer, Beca, Isaranuwatchai, Chan); Sunnybrook Health Sciences Centre (Chan), Toronto, Ont.
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yvonne Bombard
Li Ka Shing Knowledge Institute (Clausen, Mighton, Sebastian, Isaranuwatchai, Bombard), St. Michael’s Hospital, Unity Health; Institute of Health Policy, Management and Evaluation (Mighton, Sebastian, Beca, Isaranuwatchai, Bombard), University of Toronto; Canadian Cancer Society (Kiflen); Cancer Care Ontario (Dai, Mercer, Beca, Chan), Ontario Health; Canadian Centre for Applied Research in Cancer Control (Dai, Mercer, Beca, Isaranuwatchai, Chan); Sunnybrook Health Sciences Centre (Chan), Toronto, Ont.
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

Article Information

vol. 8 no. 4 E772-E778
DOI 
https://doi.org/10.9778/cmajo.20200118
PubMed 
33234584
History 
  • Published online November 24, 2020.
Copyright & Usage 
Copyright 2020, Joule Inc. or its licensors

Author Information

  1. Marc Clausen, MA,
  2. Chloe Mighton, MSc,
  3. Ruhi Kiflen, MPH,
  4. Agnes Sebastian, MSc,
  5. Wei Fang Dai, MPH,
  6. Rebecca E. Mercer, PhD,
  7. Jaclyn M. Beca, MSc,
  8. Wanrudee Isaranuwatchai, PhD,
  9. Kelvin K.W. Chan, MD PhD,
  10. Yvonne Bombard, PhD
  1. Li Ka Shing Knowledge Institute (Clausen, Mighton, Sebastian, Isaranuwatchai, Bombard), St. Michael’s Hospital, Unity Health; Institute of Health Policy, Management and Evaluation (Mighton, Sebastian, Beca, Isaranuwatchai, Bombard), University of Toronto; Canadian Cancer Society (Kiflen); Cancer Care Ontario (Dai, Mercer, Beca, Chan), Ontario Health; Canadian Centre for Applied Research in Cancer Control (Dai, Mercer, Beca, Isaranuwatchai, Chan); Sunnybrook Health Sciences Centre (Chan), Toronto, Ont.
  1. Correspondence to: Yvonne Bombard, yvonne.bombard{at}utoronto.ca
View Full Text

Usage statistics: November 2020 to September 2025

AbstractFullPdf
Nov 202016029741
Dec 202012015135
Jan 2021605519
Feb 2021524026
Mar 2021473919
Apr 202133255
May 2021382517
Jun 2021252715
Jul 20211325
Aug 202173419
Sep 202113318
Oct 202123422
Nov 202183424
Dec 202113113
Jan 202252214
Feb 20223157
Mar 2022152515
Apr 202210229
May 202252926
Jun 202252621
Jul 202273410
Aug 202291322
Sep 2022111916
Oct 20225185
Nov 2022113015
Dec 2022784
Jan 20237167
Feb 20236163
Mar 2023192
Apr 20234106
May 2023352
Jun 20234144
Jul 20230134
Aug 2023689
Sep 20234127
Oct 20233146
Nov 20234316
Dec 202371612
Jan 2024262010
Feb 20245226
Mar 20243276
Apr 2024162912
May 202452017
Jun 202454716
Jul 202473314
Aug 20241197
Sep 202473625
Oct 202422716
Nov 202444113
Dec 202452424
Jan 202511318
Feb 2025102117
Mar 2025263738
Apr 2025245529
May 2025252820
Jun 2025122225
Jul 2025641243
Aug 2025141033
Sep 202501610
PreviousNext
Back to top

In this issue

CMAJ Open: 8 (4)
Vol. 8, Issue 4
1 Oct 2020
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ Open.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Use of real-world evidence in cancer drug funding decisions in Canada: a qualitative study of stakeholders’ perspectives
(Your Name) has sent you a message from CMAJ Open
(Your Name) thought you would like to see the CMAJ Open web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Use of real-world evidence in cancer drug funding decisions in Canada: a qualitative study of stakeholders’ perspectives
Marc Clausen, Chloe Mighton, Ruhi Kiflen, Agnes Sebastian, Wei Fang Dai, Rebecca E. Mercer, Jaclyn M. Beca, Wanrudee Isaranuwatchai, Kelvin K.W. Chan, Yvonne Bombard
Oct 2020, 8 (4) E772-E778; DOI: 10.9778/cmajo.20200118

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Use of real-world evidence in cancer drug funding decisions in Canada: a qualitative study of stakeholders’ perspectives
Marc Clausen, Chloe Mighton, Ruhi Kiflen, Agnes Sebastian, Wei Fang Dai, Rebecca E. Mercer, Jaclyn M. Beca, Wanrudee Isaranuwatchai, Kelvin K.W. Chan, Yvonne Bombard
Oct 2020, 8 (4) E772-E778; DOI: 10.9778/cmajo.20200118
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Development of a framework on the incorporation of real-world evidence (RWE) into cancer drug funding decisions in Canada: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration
  • Google Scholar

Similar Articles

Collections

  • Clinical
    • Drugs
      • Other drug use
    • Oncology
      • Other oncology
  • Nonclinical
    • Medicare
      • Other medicare

Content

  • Current issue
  • Past issues
  • Collections

About

  • General Information
  • Staff
  • Editorial Board
  • Advisory Panel
  • Contact Us
  • Reprints
  • Copyright and Permissions
CMAJ Group

Copyright 2025, CMA Impact Inc. or its licensors. All rights reserved. ISSN 2291-0026

All editorial matter in CMAJ OPEN represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected].

CMA Civility, Accessibility, Privacy

 

 

Powered by HighWire